Rocket Lab Stock Climbs 28% On A 5-Day Winning Streak

A sharp five-day run has put Rocket Lab back in the spotlight, but the company’s fundamentals present a more complicated picture.

Rocket Lab (RKLB) stock has now moved higher for 5 consecutive trading days, delivering a cumulative gain of 28% over the period. That streak has added about $9.8 billion to the company’s market value, which now stands at about $45 billion. For shareholders, the run represents a sharp bounce after a steep drop: prior to this 5-day streak, the stock had fallen roughly 25.6% over the preceding three months (leaving trailing 3-month total performance at -5.0%).

The move also places the stock in a wider context. Over the trailing twelve months, it has returned +68.0%, and its current price of about $74.82 a share remains down 50.2% from its 52-week high of $150.23, though still comfortably above its 52-week low of $39.48.

RKLB Versus The S&P 500, Streak And Beyond

Here is how RKLB stock stacks up against the S&P 500 over the streak and the periods around it:

What does the data say about this run?

The evidence is genuinely mixed. On one hand, the company’s growth is significant, with revenue over the last twelve months growing 45.8%, far outpacing the S&P 500 median of 7.9%. Its 3-year average annual revenue growth is a similar 45.4%. On the other hand, its operating margin over the last twelve months is -33.2%, compared to an S&P 500 median of 18.5%.

This move appears to be specific to the stock. Over the same 5 trading days, the S&P 500 returned +5.6%. Though Rocket Lab is not an S&P 500 constituent, its 27.7% pop far exceeds the broad market momentum, where 133 index members are currently on winning streaks of 3 days or more.

So how should an investor treat a streak?

A streak is information, not an instruction. It tells you that market attention and momentum have focused on a stock, pushing its price higher. The disciplined response is not to chase the momentum, but to use the new price as a prompt to re-evaluate the underlying business.

The market is weighing rapid top-line expansion against a lack of profitability. A streak simply raises the stakes on that calculation. The numbers here provide a clear starting point for checking if the current price aligns with your own view of the company’s future.

A run like this is worth respecting, and worth testing: the momentum that lasts is usually the kind management itself is underwriting. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.

And for anyone who would rather back the theme than one company’s story, an aerospace & defense ETF like MISL owns the whole group. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.

Momentum Is A Tailwind, Not A Plan

Riding a stock that rises every day feels effortless, and that is precisely the danger: the same momentum that built this run can reverse without notice, and one name’s reversal should never be able to reset your whole year.

That is what the Trefis High Quality (HQ) Portfolio is for: about 30 quality businesses screened for the fundamentals that survive momentum’s mood swings, held with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the runs; own the resilience.